Aflofarm Farmacja Polska has launched the antibiotic Cetix, which contains the active substance cefixime. The product is available on the market in two forms of administration: 400 mg film-coated tablets and granules for oral suspension in a dose of 100 mg/5 ml, 60 ml and 100 ml. The medicine can be obtained with a prescription.
Aflofarm Farmacja Polska has launched the antibiotic Cetix, which contains the active substance cefixime. The product is available on the market in two forms of administration: 400 mg film-coated tablets and granules for oral suspension in a dose of 100 mg/5 ml, 60 ml and 100 ml. The medicine can be obtained with a prescription.Cetix is indicated for the treatment of exacerbation of chronic bronchitis, acute otitis media, uncomplicated pyelonephritis, uncomplicated acute cystitis.
We decided to introduce third-generation cephalosporin because the analyzes showed little availability of this modern drug on the Polish market. Meanwhile, antibiotics containing this substance are more effective in the treatment of inflammation of the urinary and respiratory system (in the above-mentioned indications) compared to other commonly used antibiotics. They also have a high safety profile, which is extremely important in the case of antibiotic therapy, asserts Hanna Wahl – Development Director, Member of the Board of Aflofarm Farmacja Polska.
The dose of the drug has been selected in order to facilitate compliance, i.e. the patient’s adherence to pharmacotherapy recommendations. According to studies, as much as 93% of patients apply to the treatment regimen with once-daily dosing. As for other dosages, this percentage decreases significantly, up to 40%. The active substance found in Cetix has an extremely favorable pharmacokinetic profile so that the antibiotic can be used once a day.
